Tennessee HB 2222: DNA and Genetic Testing - As enacted, requires the department of health to conduct a review and issue a report to the general assembly on variants of the apolipoprotein L1 (APOL1) gene associated with increased risk of end-stage renal disease. - Amends TCA Title 68, Chapter 5.

Status: Comp. became Pub. Ch. 838 (as of 2024-05-09)

State: Tennessee · Session: 113 · Bill: HB 2222

Subjects: DNA and Genetic Testing

Sponsors: Love

View Tennessee HB 2222 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.